25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Intra-Cellular Therapies Inc
Buy, Hold or Sell?

Let's analyze Intra-Cellular Therapies Inc together

I guess you are interested in Intra-Cellular Therapies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Intra-Cellular Therapies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Intra-Cellular Therapies Inc

I send you an email if I find something interesting about Intra-Cellular Therapies Inc.

1. Quick Overview

1.1. Quick analysis of Intra-Cellular Therapies Inc (30 sec.)










1.2. What can you expect buying and holding a share of Intra-Cellular Therapies Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€10.44
Expected worth in 1 year
€14.84
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
€4.40
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
€123.00
Expected price per share
€86.00 - €125.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Intra-Cellular Therapies Inc (5 min.)




Live pricePrice per Share (EOD)
€123.00
Intrinsic Value Per Share
€18.72 - €23.36
Total Value Per Share
€29.16 - €33.80

2.2. Growth of Intra-Cellular Therapies Inc (5 min.)




Is Intra-Cellular Therapies Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$622.8m$247.2m28.4%

How much money is Intra-Cellular Therapies Inc making?

Current yearPrevious yearGrowGrow %
Making money-$22.3m-$40.1m$17.7m79.6%
Net Profit Margin-14.3%-38.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Intra-Cellular Therapies Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Intra-Cellular Therapies Inc?

Welcome investor! Intra-Cellular Therapies Inc's management wants to use your money to grow the business. In return you get a share of Intra-Cellular Therapies Inc.

First you should know what it really means to hold a share of Intra-Cellular Therapies Inc. And how you can make/lose money.

Speculation

The Price per Share of Intra-Cellular Therapies Inc is €123.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Intra-Cellular Therapies Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Intra-Cellular Therapies Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €10.44. Based on the TTM, the Book Value Change Per Share is €1.10 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Intra-Cellular Therapies Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.26-0.2%-0.22-0.2%-0.42-0.3%-0.53-0.4%-0.53-0.4%
Usd Book Value Change Per Share-0.040.0%1.140.9%-0.25-0.2%0.830.7%0.830.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.040.0%1.140.9%-0.25-0.2%0.830.7%0.830.7%
Usd Price Per Share67.78-66.87-54.01-55.74-55.74-
Price to Earnings Ratio-65.94--81.99--34.20--41.34--41.34-
Price-to-Total Gains Ratio-1,872.07-575.69--310.32-64.66-64.66-
Price to Book Ratio6.28-8.50-8.32-7.90-7.90-
Price-to-Total Gains Ratio-1,872.07-575.69--310.32-64.66-64.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share127.2804
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.140.83
Usd Total Gains Per Share1.140.83
Gains per Quarter (7 shares)7.985.82
Gains per Year (7 shares)31.9123.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10322202313
20645404736
30968607059
4012811809382
501601500116105
601911820140128
702232140163151
802552460186174
902872780209197
1003193100233220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%4.09.00.030.8%4.09.00.030.8%4.09.00.030.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%4.09.00.030.8%4.09.00.030.8%4.09.00.030.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Intra-Cellular Therapies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0351.101-103%-0.240+587%0.803-104%0.803-104%
Book Value Per Share--10.4378.196+27%6.291+66%7.015+49%7.015+49%
Current Ratio--7.6566.500+18%8.033-5%8.687-12%8.687-12%
Debt To Asset Ratio--0.1360.164-17%0.143-5%0.140-3%0.140-3%
Debt To Equity Ratio--0.1570.197-20%0.168-7%0.164-5%0.164-5%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--6769336681.4006400243105.575+6%4895737284.315+38%5061005373.554+34%5061005373.554+34%
Eps---0.248-0.214-14%-0.406+63%-0.517+108%-0.517+108%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--9.66210.509-8%11.904-19%17.599-45%17.599-45%
Free Cash Flow Per Share---0.248-0.151-39%-0.408+64%-0.494+99%-0.494+99%
Free Cash Flow To Equity Per Share---0.1871.144-116%-0.365+96%0.284-166%0.284-166%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--23.364--------
Intrinsic Value_10Y_min--18.725--------
Intrinsic Value_1Y_max---1.223--------
Intrinsic Value_1Y_min---1.204--------
Intrinsic Value_3Y_max---0.959--------
Intrinsic Value_3Y_min---0.970--------
Intrinsic Value_5Y_max--2.581--------
Intrinsic Value_5Y_min--2.161--------
Market Cap--6942920483.0006554847777.575+6%4996424809.115+39%5169616832.115+34%5169616832.115+34%
Net Profit Margin---0.150-0.143-5%-0.387+158%-1.033+588%-1.033+588%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.3091.276+3%1.501-13%2.151-39%2.151-39%
Pb Ratio11.784+47%6.2758.502-26%8.320-25%7.902-21%7.902-21%
Pe Ratio-123.821-88%-65.937-81.987+24%-34.204-48%-41.341-37%-41.341-37%
Price Per Share123.000+47%65.50064.625+1%52.198+25%53.864+22%53.864+22%
Price To Free Cash Flow Ratio-123.904-88%-65.981693.024-110%-34.986-47%196.856-134%196.856-134%
Price To Total Gains Ratio-3515.499-88%-1872.075575.693-425%-310.316-83%64.661-2995%64.661-2995%
Quick Ratio--4.1413.575+16%5.738-28%6.090-32%6.090-32%
Return On Assets---0.021-0.024+15%-0.055+168%-0.070+239%-0.070+239%
Return On Equity---0.024-0.029+21%-0.064+170%-0.080+238%-0.080+238%
Total Gains Per Share---0.0351.101-103%-0.240+587%0.803-104%0.803-104%
Usd Book Value--1144861169.055870116729.165+32%622881884.344+84%698238905.240+64%698238905.240+64%
Usd Book Value Change Per Share---0.0361.140-103%-0.249+587%0.831-104%0.831-104%
Usd Book Value Per Share--10.8018.481+27%6.510+66%7.259+49%7.259+49%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--7004909597.9136622971565.649+6%5066108941.809+38%5237128360.553+34%5237128360.553+34%
Usd Eps---0.257-0.221-14%-0.420+63%-0.535+108%-0.535+108%
Usd Free Cash Flow---27221836.229-15727983.149-42%-40393990.865+48%-46850807.905+72%-46850807.905+72%
Usd Free Cash Flow Per Share---0.257-0.156-39%-0.422+64%-0.511+99%-0.511+99%
Usd Free Cash Flow To Equity Per Share---0.1931.184-116%-0.378+96%0.293-166%0.293-166%
Usd Market Cap--7184534115.8086782956480.235+6%5170300392.472+39%5349519497.872+34%5349519497.872+34%
Usd Price Per Share127.280+47%67.77966.874+1%54.014+25%55.738+22%55.738+22%
Usd Profit---27240075.200-22343919.000-18%-40129802.700+47%-49062490.104+80%-49062490.104+80%
Usd Revenue--181254533.200158527220.800+14%108162987.400+68%98680692.244+84%98680692.244+84%
Usd Total Gains Per Share---0.0361.140-103%-0.249+587%0.831-104%0.831-104%
 EOD+3 -3MRQTTM+17 -18YOY+30 -55Y+24 -1110Y+24 -11

3.3 Fundamental Score

Let's check the fundamental score of Intra-Cellular Therapies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-123.821
Price to Book Ratio (EOD)Between0-111.784
Net Profit Margin (MRQ)Greater than0-0.150
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.141
Current Ratio (MRQ)Greater than17.656
Debt to Asset Ratio (MRQ)Less than10.136
Debt to Equity Ratio (MRQ)Less than10.157
Return on Equity (MRQ)Greater than0.15-0.024
Return on Assets (MRQ)Greater than0.05-0.021
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Intra-Cellular Therapies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose121.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Intra-Cellular Therapies Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Intra-Cellular Therapies Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • A Net Profit Margin of -15.0% means that €-0.15 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Intra-Cellular Therapies Inc:

  • The MRQ is -15.0%. The company is making a huge loss. -2
  • The TTM is -14.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.0%TTM-14.3%-0.7%
TTM-14.3%YOY-38.7%+24.4%
TTM-14.3%5Y-103.3%+89.0%
5Y-103.3%10Y-103.3%0.0%
4.3.1.2. Return on Assets

Shows how efficient Intra-Cellular Therapies Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • -2.1% Return on Assets means that Intra-Cellular Therapies Inc generated €-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Intra-Cellular Therapies Inc:

  • The MRQ is -2.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.1%TTM-2.4%+0.3%
TTM-2.4%YOY-5.5%+3.1%
TTM-2.4%5Y-7.0%+4.6%
5Y-7.0%10Y-7.0%0.0%
4.3.1.3. Return on Equity

Shows how efficient Intra-Cellular Therapies Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • -2.4% Return on Equity means Intra-Cellular Therapies Inc generated €-0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Intra-Cellular Therapies Inc:

  • The MRQ is -2.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-2.9%+0.5%
TTM-2.9%YOY-6.4%+3.6%
TTM-2.9%5Y-8.0%+5.2%
5Y-8.0%10Y-8.0%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Intra-Cellular Therapies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Intra-Cellular Therapies Inc is operating .

  • Measures how much profit Intra-Cellular Therapies Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Intra-Cellular Therapies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Intra-Cellular Therapies Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are €1.31 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Intra-Cellular Therapies Inc:

  • The MRQ is 1.309. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.276. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.309TTM1.276+0.033
TTM1.276YOY1.501-0.225
TTM1.2765Y2.151-0.875
5Y2.15110Y2.1510.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Intra-Cellular Therapies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Intra-Cellular Therapies Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 7.66 means the company has €7.66 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Intra-Cellular Therapies Inc:

  • The MRQ is 7.656. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.500. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.656TTM6.500+1.156
TTM6.500YOY8.033-1.533
TTM6.5005Y8.687-2.187
5Y8.68710Y8.6870.000
4.4.3.2. Quick Ratio

Measures if Intra-Cellular Therapies Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • A Quick Ratio of 4.14 means the company can pay off €4.14 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Intra-Cellular Therapies Inc:

  • The MRQ is 4.141. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.575. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.141TTM3.575+0.566
TTM3.575YOY5.738-2.163
TTM3.5755Y6.090-2.515
5Y6.09010Y6.0900.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Intra-Cellular Therapies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Intra-Cellular Therapies Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Intra-Cellular Therapies Inc to industry mean.
  • A Debt to Asset Ratio of 0.14 means that Intra-Cellular Therapies Inc assets are financed with 13.6% credit (debt) and the remaining percentage (100% - 13.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Intra-Cellular Therapies Inc:

  • The MRQ is 0.136. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.164. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.136TTM0.164-0.028
TTM0.164YOY0.143+0.020
TTM0.1645Y0.140+0.023
5Y0.14010Y0.1400.000
4.5.4.2. Debt to Equity Ratio

Measures if Intra-Cellular Therapies Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • A Debt to Equity ratio of 15.7% means that company has €0.16 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Intra-Cellular Therapies Inc:

  • The MRQ is 0.157. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.197. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.157TTM0.197-0.040
TTM0.197YOY0.168+0.029
TTM0.1975Y0.164+0.033
5Y0.16410Y0.1640.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Intra-Cellular Therapies Inc generates.

  • Above 15 is considered overpriced but always compare Intra-Cellular Therapies Inc to the  industry mean.
  • A PE ratio of -65.94 means the investor is paying €-65.94 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Intra-Cellular Therapies Inc:

  • The EOD is -123.821. Based on the earnings, the company is expensive. -2
  • The MRQ is -65.937. Based on the earnings, the company is expensive. -2
  • The TTM is -81.987. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-123.821MRQ-65.937-57.884
MRQ-65.937TTM-81.987+16.050
TTM-81.987YOY-34.204-47.783
TTM-81.9875Y-41.341-40.646
5Y-41.34110Y-41.3410.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Intra-Cellular Therapies Inc:

  • The EOD is -123.904. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -65.981. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 693.024. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-123.904MRQ-65.981-57.923
MRQ-65.981TTM693.024-759.006
TTM693.024YOY-34.986+728.011
TTM693.0245Y196.856+496.168
5Y196.85610Y196.8560.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Intra-Cellular Therapies Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 6.28 means the investor is paying €6.28 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Intra-Cellular Therapies Inc:

  • The EOD is 11.784. Based on the equity, the company is expensive. -2
  • The MRQ is 6.275. Based on the equity, the company is overpriced. -1
  • The TTM is 8.502. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.784MRQ6.275+5.509
MRQ6.275TTM8.502-2.226
TTM8.502YOY8.320+0.181
TTM8.5025Y7.902+0.599
5Y7.90210Y7.9020.000
4.6.2. Total Gains per Share

2.4. Latest News of Intra-Cellular Therapies Inc

Does Intra-Cellular Therapies Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Intra-Cellular Therapies Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-01-22
18:03
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe WolkRead
2025-01-22
16:22
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earningsRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,324,445
Total Liabilities179,619
Total Stockholder Equity1,144,826
 As reported
Total Liabilities 179,619
Total Stockholder Equity+ 1,144,826
Total Assets = 1,324,445

Assets

Total Assets1,324,445
Total Current Assets1,271,731
Long-term Assets52,714
Total Current Assets
Cash And Cash Equivalents 464,312
Short-term Investments 542,250
Net Receivables 145,608
Inventory 23,539
Other Current Assets 94,272
Total Current Assets  (as reported)1,271,731
Total Current Assets  (calculated)1,269,981
+/- 1,750
Long-term Assets
Property Plant Equipment 16,016
Long-term Assets Other 36,698
Long-term Assets  (as reported)52,714
Long-term Assets  (calculated)52,714
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities166,113
Long-term Liabilities13,506
Total Stockholder Equity1,144,826
Total Current Liabilities
Accounts payable 10,338
Total Current Liabilities  (as reported)166,113
Total Current Liabilities  (calculated)10,338
+/- 155,775
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt17,709
Long-term Liabilities  (as reported)13,506
Long-term Liabilities  (calculated)17,709
+/- 4,203
Total Stockholder Equity
Total Stockholder Equity (as reported)1,144,826
Total Stockholder Equity (calculated)0
+/- 1,144,826
Other
Capital Stock11
Common Stock Shares Outstanding 105,999
Net Invested Capital 1,144,826
Net Working Capital 1,105,618
Property Plant and Equipment Gross 16,016



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
556,976
489,922
868,580
811,906
781,999
754,780
722,158
713,602
717,664
728,295
747,036
1,320,504
1,324,445
1,324,4451,320,504747,036728,295717,664713,602722,158754,780781,999811,906868,580489,922556,976
   > Total Current Assets 
533,243
467,281
848,342
789,206
759,756
737,957
706,094
698,073
702,425
667,799
690,527
1,264,251
1,271,731
1,271,7311,264,251690,527667,799702,425698,073706,094737,957759,756789,206848,342467,281533,243
       Cash And Cash Equivalents 
106,126
92,365
129,295
77,235
135,358
148,615
75,727
142,258
99,402
147,767
139,819
693,306
464,312
464,312693,306139,819147,76799,402142,25875,727148,615135,35877,235129,29592,365106,126
       Short-term Investments 
371,158
319,968
642,553
600,594
493,383
443,290
462,981
370,596
393,619
350,174
335,804
329,601
542,250
542,250329,601335,804350,174393,619370,596462,981443,290493,383600,594642,553319,968371,158
       Net Receivables 
16,934
20,156
32,832
46,976
61,538
75,189
81,545
95,964
102,670
114,018
131,157
145,714
145,608
145,608145,714131,157114,018102,67095,96481,54575,18961,53846,97632,83220,15616,934
       Inventory 
8,167
7,948
7,893
25,022
23,597
23,920
28,341
41,895
42,986
11,647
15,949
20,082
23,539
23,53920,08215,94911,64742,98641,89528,34123,92023,59725,0227,8937,9488,167
   > Long-term Assets 
23,733
22,641
20,238
22,700
22,243
16,823
16,064
15,529
15,239
60,496
56,509
56,253
52,714
52,71456,25356,50960,49615,23915,52916,06416,82322,24322,70020,23822,64123,733
       Property Plant Equipment 
0
0
0
0
22,157
16,737
15,978
15,443
15,153
14,582
14,003
15,952
16,016
16,01615,95214,00314,58215,15315,44315,97816,73722,1570000
       Long-term Assets Other 
86
86
86
86
86
86
86
86
86
45,914
42,506
40,301
36,698
36,69840,30142,50645,914868686868686868686
> Total Liabilities 
70,219
72,031
75,830
89,709
96,577
98,710
94,548
106,512
116,983
136,871
147,538
175,892
179,619
179,619175,892147,538136,871116,983106,51294,54898,71096,57789,70975,83072,03170,219
   > Total Current Liabilities 
49,896
53,356
59,074
70,634
77,410
83,236
79,587
92,080
103,092
123,545
134,801
161,775
166,113
166,113161,775134,801123,545103,09292,08079,58783,23677,41070,63459,07453,35649,896
       Accounts payable 
12,031
8,691
11,649
10,749
14,219
10,395
8,441
7,733
10,613
11,452
11,532
17,548
10,338
10,33817,54811,53211,45210,6137,7338,44110,39514,21910,74911,6498,69112,031
   > Long-term Liabilities 
20,324
18,675
16,756
19,075
19,167
15,474
14,961
14,432
13,891
13,326
12,737
14,117
13,506
13,50614,11712,73713,32613,89114,43214,96115,47419,16719,07516,75618,67520,324
       Capital Lease Obligations Min Short Term Debt
26,406
25,407
24,392
26,818
26,412
20,041
18,492
17,990
17,475
16,938
16,376
18,288
17,709
17,70918,28816,37616,93817,47517,99018,49220,04126,41226,81824,39225,40726,406
> Total Stockholder Equity
486,756
417,891
792,750
722,197
685,422
656,070
627,610
607,090
600,681
591,424
599,498
1,144,612
1,144,826
1,144,8261,144,612599,498591,424600,681607,090627,610656,070685,422722,197792,750417,891486,756
   Common Stock0000000000000
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 0000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue462,175
Cost of Revenue-33,745
Gross Profit428,430428,430
 
Operating Income (+$)
Gross Profit428,430
Operating Expense-621,556
Operating Income-159,381-193,126
 
Operating Expense (+$)
Research Development180,142
Selling General Administrative409,864
Selling And Marketing Expenses-
Operating Expense621,556590,006
 
Net Interest Income (+$)
Interest Income20,343
Interest Expense--
Other Finance Cost-0
Net Interest Income20,343
 
Pretax Income (+$)
Operating Income-159,381
Net Interest Income20,343
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-139,038-159,381
EBIT - interestExpense = 0
-139,674
-139,674
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--139,038
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-139,038
Tax Provision-636
Net Income From Continuing Ops-139,674-139,674
Net Income-139,674
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--20,343
 

Technical Analysis of Intra-Cellular Therapies Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Intra-Cellular Therapies Inc. The general trend of Intra-Cellular Therapies Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Intra-Cellular Therapies Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Intra-Cellular Therapies Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 122.00 < 125.00.

The bearish price targets are: 118.00 > 86.00 > 86.00.

Tweet this
Intra-Cellular Therapies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Intra-Cellular Therapies Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Intra-Cellular Therapies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Moving Average Convergence/Divergence (MACD) ChartIntra-Cellular Therapies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Intra-Cellular Therapies Inc. The current adx is .

Intra-Cellular Therapies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Relative Strength Index (RSI) ChartIntra-Cellular Therapies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Stochastic Oscillator ChartIntra-Cellular Therapies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Commodity Channel Index (CCI) ChartIntra-Cellular Therapies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Chande Momentum Oscillator (CMO) ChartIntra-Cellular Therapies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Williams %R ChartIntra-Cellular Therapies Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Average True Range (ATR) ChartIntra-Cellular Therapies Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily On-Balance Volume (OBV) ChartIntra-Cellular Therapies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc Daily Money Flow Index (MFI) ChartIntra-Cellular Therapies Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Intra-Cellular Therapies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Intra-Cellular Therapies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Intra-Cellular Therapies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose121.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Intra-Cellular Therapies Inc with someone you think should read this too:
  • Are you bullish or bearish on Intra-Cellular Therapies Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Intra-Cellular Therapies Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Intra-Cellular Therapies Inc

I send you an email if I find something interesting about Intra-Cellular Therapies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Intra-Cellular Therapies Inc.

Receive notifications about Intra-Cellular Therapies Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.